While the FDA's final decision is pending, this recommendation is a key regulatory step that could facilitate Vanta's planned peptide commercialization in the U.S
GSH brain concentrations are not commonly measured using 1 H-MRS, because relative to other 1 H-MRS-detectable neurochemicals (e.g., creatine (Cr), choline, N -acetylasparate), GSH concentrations are substantially lower
These formulations often contain additional ingredients such as stabilizers, binders, fillers, carrier solutions, or excipients that support the final product format
Frequent use increases the overall expense due to the need for more medication and supplies like needles and syringes
Improvements in symptoms can be noticeable within a few days to weeks of starting supplementation